Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620087 · ClinicalTrials.gov registry record · NA
Molecular Breast Imaging in Women With Atypia and LCIS
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT00620087: Completed NA study, sponsored by Mayo Clinic.
NCT00620087 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00620087, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
We aim to determine if Molecular Breast Imaging (a new nuclear medicine technique developed at Mayo) can identify malignant breast lesions in women who have atypical ductal hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in situ.
Interventions
- PROCEDURE Molecular Breast Imaging
- PROCEDURE Screening Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2003-08 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00620087
The ClinicalTrials.gov registry entry for NCT00620087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Molecular Breast Imaging is the first listed.
NCT00620087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00620087 about?
NCT00620087 is a clinical study titled "Molecular Breast Imaging in Women With Atypia and LCIS". We aim to determine if Molecular Breast Imaging (a new nuclear medicine technique developed at Mayo) can identify malignant breast lesions in women who have atypical ductal hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in situ.
What is the current status of trial NCT00620087?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2003-08. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00620087?
The interventions under investigation include: Molecular Breast Imaging (PROCEDURE), Screening Mammography (PROCEDURE).
Who is sponsoring clinical trial NCT00620087?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.